Hyperoxaluria, Primary: all 42 studies

Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.

• Follow-up of Pediatric Patients Affected by Primary Hyperoxaluria Type 1 (PH1) Treated With LumasiranEnrolling by invitationNCT07874074
• Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1)RecruitingNCT07776626Phase 1
• Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)RecruitingNCT07587021Phase 2
• Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)RecruitingNCT06839235Phase 1/2
• Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3RecruitingNCT06465472Phase 3
• National Registry of Rare Kidney DiseasesRecruitingNCT06065852
• Genetic Newborn Screening for Cystinosis and Primary HyperoxaluriaRecruitingNCT05843851Not applicable
• Monogenic Kidney Stone - Genetic TestingRecruitingNCT03305835
• Prospective Research Rare Kidney Stones (ProRKS)RecruitingNCT02780297
• Rare Kidney Stone Consortium BiobankRecruitingNCT02026388
• Rare Kidney Stone Consortium Patient RegistryRecruitingNCT00588562
• Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal FunctionCompletedNCT05001269Phase 2Results posted
• A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1CompletedNCT04152200Phase 3Results posted
• An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary HyperoxaluriaTerminatedNCT03938272Phase 3Results posted
• A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1CompletedNCT03905694Phase 3Results posted
• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2CompletedNCT03847909Phase 2Results posted
• A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1CompletedNCT03681184Phase 3Results posted
• An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1CompletedNCT03350451Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary HyperoxaluriaCompletedNCT03116685Phase 3Results posted
• Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1CompletedNCT02706886Phase 1/2Results posted
• Hydroxyproline Influence on Oxalate MetabolismCompletedNCT02038543Phase 1/2Results posted
• Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on DialysisCompletedNCT02000219Phase 2Results posted
• Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary HyperoxaluriaCompletedNCT00283387Phase 2Results posted
• Baby Detect : Genomic Newborn ScreeningCompletedNCT05687474
• Phenotyping of Primary HyperoxaluriaStatus unknownNCT05107830
• Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 PatientsCompletedNCT04555486Phase 1
• Natural History of Patients With PH3 and a History of Stone EventsCompletedNCT04542590
• Expanded Access Protocol to Provide Lumasiran to Patients With Primary Hyperoxaluria Type 1Approved for marketingNCT04125472
• Long Term Extension Study in Patients With Primary HyperoxaluriaActive, not recruitingNCT04042402Phase 3
• Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary HyperoxaluriaCompletedNCT03819647Phase 2
• Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary HyperoxaluriaCompletedNCT03392896Phase 1
• Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and HyperoxalemiaCompletedNCT03391804Phase 2
• Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric PatientsStatus unknownNCT02794649
• Primary Hyperoxaluria Mutation Genotyping/PhenotypingCompletedNCT02340689
• Health-related Quality of Life in Rare Kidney StoneCompletedNCT02124395
• Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary HyperoxaluriaCompletedNCT02012985Phase 1/2
• Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphateCompletedNCT01281878Phase 2
• Phase 2/3 Oxabact StudyCompletedNCT01037231Phase 2/3
• International Registry for Primary HyperoxaluriaWithdrawnNCT00875823
• Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria PatientsCompletedNCT00638703Phase 2/3
• Primary Hyperoxaluria Mutation GenotypingCompletedNCT00589225
• Renal Protective Effect of ACEI and ARB in Primary HyperoxaluriaWithdrawnNCT00280215Phase 3

← Hyperoxaluria, Primary overview